Radioprotective effect of mefenamic acid against radiation-induced genotoxicity in human lymphocytes

Seyed Jalal Hosseinimehr1, Reyhaneh Nobakht1, Arash Ghasemi2

  • 1Department of Radiopharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

Abstract

Insights

Mefenamic acid (MEF) shows radioprotective effects against ionizing radiation in human lymphocytes. MEF significantly reduced radiation-induced DNA damage, with optimal protection observed at 100 µM concentration.

Area of Science:

  • Pharmacology
  • Radiation Biology
  • Genetics

Background:

  • Mefenamic acid (MEF) is a non-steroidal anti-inflammatory drug.
  • Ionizing radiation induces inflammation, DNA damage, and cell death.
  • Investigating radioprotective agents is crucial for mitigating radiation effects.

Purpose of the Study:

  • To evaluate the radioprotective potential of MEF against genotoxicity induced by ionizing radiation.
  • To assess the effect of MEF on DNA damage in human blood lymphocytes exposed to radiation.

Main Methods:

  • Human peripheral blood lymphocytes were treated with varying concentrations of MEF (5–100 µM).
  • The treated blood samples were exposed to 1.5 Gy of ionizing radiation.
  • Micronuclei formation in binucleated lymphocytes was analyzed to quantify DNA damage.

Main Results:

  • MEF treatment significantly decreased the frequency of radiation-induced micronuclei in lymphocytes.
  • A dose-dependent protective effect was observed, with 100 µM MEF showing the maximum reduction (38%).
  • MEF demonstrated significant radioprotective efficacy against ionizing radiation-induced genotoxicity.

Conclusions:

  • MEF exhibits significant radioprotective properties in human lymphocytes.
  • The anti-inflammatory action of MEF likely contributes to its radioprotective effect.
  • MEF is a potential candidate for mitigating radiation-induced DNA damage.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
5.7K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Other Unique Bacteria01:18

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
538